We thank Tavakkoli and colleagues for their interest in our recent review of gastric cancer progress and priorities (1), which included discussion of the higher gastric cancer incidence rates among all racial and ethnic minorities compared with non-Hispanic Whites, and specifically higher mortality rates among Black and Hispanic patients with non-cardia gastric cancer. We concluded that persistent disparities in incidence and mortality warrant risk-stratified prevention and interception strategies. We recognize the point raised by Tavakkoli and colleagues that, while we also reviewed the trend of increasing incidence of early-onset non-cardia gastric cancer among non-Hispanic White women, we did not acknowledge the mounting evidence of a similar trend among Hispanic White persons in the United States. We greatly appreciate Tavakkoli and colleagues bringing our attention to this important aspect of the changing demographics of early-onset non-cardia gastric cancer, and the need for additional research to understand, and ultimately prevent,...
Skip Nav Destination
Article navigation
1 September 2023
Letters to the Editor|
September 01 2023
Cancer Progress and Priorities: Gastric Cancer—Reply
Priya Alagesan
;
Priya Alagesan
*
1Duke University School of Medicine, Durham, North Carolina.
*Corresponding Author: Priya Alagesan, Duke University School of Medicine, Durham, NC 27701. E-mail: [email protected]
Search for other works by this author on:
Jessica C. Goodwin
;
Jessica C. Goodwin
2Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina.
3Morehouse School of Medicine, Atlanta, Georgia.
Search for other works by this author on:
Katherine S. Garman
;
Katherine S. Garman
4Cancer Risk, Detection, and Interception Program, Duke Cancer Institute, Durham, North Carolina.
5Division of Gastroenterology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Search for other works by this author on:
Meira Epplein
Meira Epplein
2Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina.
4Cancer Risk, Detection, and Interception Program, Duke Cancer Institute, Durham, North Carolina.
Search for other works by this author on:
*Corresponding Author: Priya Alagesan, Duke University School of Medicine, Durham, NC 27701. E-mail: [email protected]
Cancer Epidemiol Biomarkers Prev 2023;32:1271
Received:
May 13 2023
Revision Received:
June 20 2023
Accepted:
June 20 2023
Online ISSN: 1538-7755
Print ISSN: 1055-9965
Funding
Funding Group:
- Award Group:
- Funder(s): National Cancer Institute (NCI)
- Award Id(s): CA251657
- Principal Award Recipient(s): K.S.M.GarmanEpplein
- Funder(s):
- Award Group:
- Funder(s): National Cancer Institute (NCI)
- Award Id(s): CA014236
- Principal Award Recipient(s): M.K.S.EppleinGarman
- Funder(s):
©2023 American Association for Cancer Research
2023
American Association for Cancer Research
Cancer Epidemiol Biomarkers Prev (2023) 32 (9): 1271.
Article history
Received:
May 13 2023
Revision Received:
June 20 2023
Accepted:
June 20 2023
Related Content
A letter has been published:
Cancer Progress and Priorities: Gastric Cancer—Letter
- Views Icon Views
- Share Icon Share
-
Tools Icon
Tools
- Search Site
-
Article Versions Icon
Versions
- Version of Record September 1 2023
Citation
Priya Alagesan, Jessica C. Goodwin, Katherine S. Garman, Meira Epplein; Cancer Progress and Priorities: Gastric Cancer—Reply. Cancer Epidemiol Biomarkers Prev 1 September 2023; 32 (9): 1271. https://doi.org/10.1158/1055-9965.EPI-23-0533
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Pay-Per-View 24-Hour Access
$50.00
Advertisement
231
Views